This process is promoted by PINK1 kinase via phosphorylating Rab22a‐NeoF1 at serine120, and Sorafenib and Regorafenib can diminish osteosarcoma lung metastasis induced by Rab22a‐NeoF1 through upregulating PINK1. This evidence concerns the gene PINK1 and osteosarcoma.